Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland as a location and removed the Maryland Locations entry. Removed the HHS Vulnerability Disclosure footer and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T12:17:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)', replacing the previous labels.
    Difference
    0.1%
    Check dated 2025-12-02T16:47:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a Results Posted entry with attribution to the National Cancer Institute (NCI) and Jing Wu, M.D., dated 2025-11-24, and expanded study results content; removed the NIH Clinical Center location and the 'Results Submitted' text.
    Difference
    6%
    Check dated 2025-11-25T11:12:21.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The funding-lapse warning text was removed from the page. Previously, the notice warned that information may not be up to date and that operations might be disrupted until appropriations are enacted.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:18.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Minor formatting and layout updates across the page; no changes to core study data such as eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:03:58.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:36:21.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.